Skip to main contentSkip to navigation
Sirius Investors
Myovant Sciences Ltd.

Myovant Sciences Ltd.

MYOV
NYSEHealthcare

Revenue Analysis - MYOV

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

MYOV Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Product

0.0% of total revenue

$61.4M

ORGOVYX

0.0% of total revenue

$48.7M

MYFEMBREE

0.0% of total revenue

$10.5M

License

0.0% of total revenue

$5.0M

License and Service

0.0% of total revenue

$4.0M

Richter Product Supply and Royalties

0.0% of total revenue

$1.8M

Product and Service, Other

0.0% of total revenue

$500.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
License
License and Service
MYFEMBREE
ORGOVYX
Product
Product and Service, Other
RYEQO
Richter Product Supply and Royalties
12/31/2022$5.0M$4.0M$10.5M$48.7M$61.4M$500.0K$0$1.8M
9/30/2022$0$300.0K$6.4M$43.3M$49.9M$0$0$225.0K
6/30/2022$50.0M$0$4.0M$36.0M$41.4M$0$0$1.3M
3/31/2022$0$0$2.2M$29.4M$32.4M$0$0$778.0K
12/31/2021$0$0$2.4M$24.4M$29.3M$0$0$2.4M
9/30/2021$0$31.7M$629.0K$18.7M$21.1M$0$1.8M$0

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
License and Service+1233.3%
Richter Product Supply and Royalties+692.9%
MYFEMBREE+64.4%

Earnings Reports

Want to see how MYOV's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports